Cannabis Microdosing Stalls Decline in Alzheimer's Patients
A small Brazilian study finds that cannabis microdosing can stall cognitive decline in Alzheimer’s patients without psychoactive effects. Read more on the latest research.
BRAZIL- A clinical trial conducted in Brazil has revealed that microdosing cannabis extract can effectively stall cognitive decline in mild Alzheimer’s patients. Unlike recreational use, these sub-psychoactive doses provide therapeutic benefits for memory and focus without inducing the associated "high" or euphoria.
Published in the Journal of Alzheimer's Disease, the study highlights how minimal concentrations of THC and CBD reduce neuroinflammation. Researchers suggest that this safe and accessible approach could transform future dementia care, offering a vital alternative to currently limited medical treatments.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
